Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression

Autor: Georg Bartsch, Reinhold Ramoner, Boe Sandahl-Sorensen, Erika Artner-Dworzak, Sonia Godoy-Tundidor, Zoran Culig, Matthias Fiechtl, Alfred Hobisch

Publikováno v: Hobisch, A, Fiechtl, M, Sørensen, B S, Godoy-Tundidor, S, Artner-Dworzak, E, Ramoner, R, Bartsch, G & Culig, Z 2004, ' Prostate Cancer Cells Generated During Intermittent Androgen Ablation Acquire a Growth Advantage and Exhibit Changes in Epidermal Growth Factor Receptor Expression ', Prostate, no. 59, pp. 401-408 . < http://www.interscience.wiley.com >

BACKGROUND Intermittent androgen ablation is a palliative treatment option for advanced prostate cancer which is associated with less side effects, improved quality of life of patients, and reduced costs. Regulation of growth and survival of prostate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37ba19b96f7ca92533fc79ab0e07d8b0
https://doi.org/10.1002/pros.10372

Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase

Autor: Dietmar Fuchs, Katrin Friedbichler, Matthias Fiechtl, Zoran Culig, Alfred Hobisch, Georg Bartsch, Ilaria T. Cavarretta, Hannes Steiner, Sonia Godoy-Tundidor

Publikováno v: The Prostate. 64(2)

INTRODUCTION Interleukin-6 (IL-6) is a pleiotropic regulator of prostate cancer cell growth. Oncostatin M (OSM), an IL-6-type cytokine, affects the growth of prostate cancers in a paracrine and autocrine manner. In order to understand better the mech

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4f61005312414177ff4023cde8c9d56
https://pubmed.ncbi.nlm.nih.gov/15712220

The androgen receptor pathway is by‐passed in prostate cancer cells generated after prolonged treatment with bicalutamideAndreas Fritzer and Barbara Comuzzi contributed equally to this work.

Autor: Alfred Hobisch, Andreas Fritzer, Barbara Comuzzi, Matthias Fiechtl, Kamilla Malinowska, Hannes Steiner, Georg Bartsch, Zoran Culig

Publikováno v: Prostate; Mar2006, Vol. 66 Issue 4, p413-420, 8p

Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression.

Autor: Alfred Hobisch, Matthias Fiechtl, Boe Sandahl-Sorensen, Sonia Godoy-Tundidor, Erika Artner-Dworzak, Reinhold Ramoner, Georg Bartsch, Zoran Culig

Publikováno v: Prostate; Jun2004, Vol. 59 Issue 4, p401-408, 8p